Cyclo Therapeutics- Warrants (14/11/2025) Total Current Liabilities

As of the most recent data (September 2024), CYTHW shows a total current liabilities of $19M. That compares with $6.6M in the prior-year period — up 182.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's total current liabilities is now $19M (was $6.6M) — a 182.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

Tracking CYTHW's total current liabilities over time shows whether Cyclo Therapeutics- Warrants (14/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $19M That compares with $6.6M in the prior-year period — up 182.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $19M) with ownership activity and broader fundamentals.

Cyclo Therapeutics- Warrants (14/11/2025)'s total current liabilities is $19M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.